Moreover, restoration of the expression of EZH2 in gastric cancer cells stably expressing miR-217 was able to counteract the tumor-suppressive effects of miR-217, whereas the knockdown of EZH2 in these cells was able to mimic the tumor suppressive effects of miR-217. This evidence concerns the gene EZH2 and gastric cancer.